Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic and Affy Amend Terms of Microarray Supply Agreement; Subscription Payment to Affy Slashed

NEW YORK, Dec. 30 (GenomeWeb News) - Gene Logic yesterday announced amendments to its 2002 microarray supply agreement with Affymetrix.


In an SEC filing, Gene Logic said that it will pay Affymetrix a mere $500,000 in annual subscription fees in 2005, instead of $4 million that it paid in prior years.


Gene Logic also said it will purchase at least $500,000 worth of Affymetrix products and services this month, and at least another $9.5 million in 2005.


The companies will also establish pricing for probe array products for the period between July 1, 2003 and Dec. 31, 2005.


The original contract, effective since Jan. 1, 2002, sets the terms for supplying Gene Logic and its subsidiaries with DNA probe arrays from Affymetrix for developing database products and services. That agreement, disclosed in a 2002 SEC filing by Gene Logic, did not provide any financial details.


The two companies first announced a supply agreement in January of 1999, which the 2002 agreement replaced.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more